Kirill A Martemyanov
Overview
Explore the profile of Kirill A Martemyanov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
152
Citations
4198
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Curtis M, Alexander S, Cortese-Krott M, Kendall D, Martemyanov K, Mauro C, et al.
Br J Pharmacol
. 2025 Jan;
182(7):1413-1415.
PMID: 39865712
No abstract available.
2.
Shishikura K, Li J, Chen Y, McKnight N, Bustin K, Barr E, et al.
bioRxiv
. 2025 Jan;
PMID: 39803451
The vasodilator hydralazine (HYZ) has been used clinically for ~ 70 years and remains on the World Health Organization's List of Essential Medicines as a therapy for preeclampsia. Despite its...
3.
Dunn H, Dhaliwal S, Chang C, Martemyanov K
J Biol Chem
. 2024 Dec;
301(1):108073.
PMID: 39675706
Synaptic adhesion molecules are essential components of the synapse, yet the diversity of these molecules and their associated functions remain to be fully characterized. Extracellular leucine rich repeat and fibronectin...
4.
Luo H, Anderson A, Masuho I, Marron Fernandez de Velasco E, Birnbaumer L, Martemyanov K, et al.
Prog Neurobiol
. 2024 Nov;
243:102686.
PMID: 39542413
Most neurons are influenced by multiple neuromodulatory inputs that converge on common effectors. Mechanisms that route these signals are key to selective neuromodulation but are poorly understood. G protein-gated inwardly...
5.
Yun Y, Jeong H, Laboute T, Martemyanov K, Lee H
Nat Commun
. 2024 Oct;
15(1):9083.
PMID: 39433729
No abstract available.
6.
Yun Y, Jeong H, Laboute T, Martemyanov K, Lee H
Nat Commun
. 2024 Sep;
15(1):8299.
PMID: 39333506
GPR179, an orphan class C GPCR, is expressed at the dendritic tips of ON-bipolar cells in the retina. It plays a pivotal role in the initial synaptic transmission of visual...
7.
Wang X, Izzo A, Papapetropoulos A, Alexander S, Cortese-Krott M, Kendall D, et al.
Br J Pharmacol
. 2024 Aug;
181(19):3547-3555.
PMID: 39128855
Natural products (NPs) have long been used as a rich source of bioactive compounds for drug development. Recent technological advancements have revitalised natural products research as evidenced by increased publications...
8.
Knight K, Krumm B, Kapolka N, Ludlam W, Cui M, Mani S, et al.
Nat Commun
. 2024 Aug;
15(1):6643.
PMID: 39103320
Many neurotransmitter receptors activate G proteins through exchange of GDP for GTP. The intermediate nucleotide-free state has eluded characterization, due largely to its inherent instability. Here we characterize a G...
9.
Ludlam W, Soliani L, Dominguez-Carral J, Cordelli D, Marchiani V, Gorria-Redondo N, et al.
J Neurol
. 2024 May;
271(7):3777-3781.
PMID: 38724739
No abstract available.
10.
Papapetropoulos A, Topouzis S, Alexander S, Cortese-Krott M, Kendall D, Martemyanov K, et al.
Br J Pharmacol
. 2024 Mar;
181(11):1553-1575.
PMID: 38519837
In 2023, seventy novel drugs received market authorization for the first time in either Europe (by the EMA and the MHRA) or in the United States (by the FDA). Confirming...